In the current study, we have found that PRKCQ‐AS1 knockdown reduces MYCN nonamplified neuroblastoma cell proliferation, considerably inhibits clonogenic capacity, suppresses tumor progression and improves survival in two mouse models. The gene discussed is MYCN; the disease is neoplasm.